EV/EBITDA
-1.02
+0.01+0.97%
Fri, 07 Feb 2025 21:02:59 GMT
Summary
- As of February 8, 2025, RNAC EV/EBITDA is -1.02, with a rise of +0.01 (+0.97%) during the most recent trading day.
- Over the past year, RNAC EV/EBITDA has dropped by -0.86 (-537.50%).
- RNAC EV/EBITDA is now -118.02% below its all-time high of 5.66.
Performance
RNAC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RNAC EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.0% | -1.3% | -0.8% |
| 1 m1 month | -13.3% | +13.0% | +7.0% |
| 3 m3 months | +6.4% | -6.4% | -4.9% |
| 6 m6 months | -9.7% | +17.1% | +30.4% |
| ytdytd | -5.2% | +4.5% | +2.5% |
| 1 y1 year | -537.5% | +601.6% | -4.8% |
| 5 y5 years | +83.1% | -16.2% | -86.5% |
RNAC EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -21.4% | -1.21 | +15.7% | |
| 3 m | 3-month | -0.83 | -22.9% | -1.61 | +36.6% |
| 6 m | 6-month | -0.29 | -251.7% | -1.61 | +36.6% |
| 1 y | 1-year | 0.07 | -1557.1% | -2.12 | +51.9% |
| 3 y | 3-year | 5.66 | -118.0% | -37.42 | +97.3% |
| 5 y | 5-year | 5.66 | -118.0% | -60.03 | +98.3% |
| alltime | all time | 5.66 | -118.0% | -60.03 | +98.3% |
Cartesian Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.02(+5.2%) |
| 2024 | -0.97(+410.5%) |
| 2023 | -0.19(-107.1%) |
| 2022 | 2.67(-104.6%) |
| 2021 | -57.64(+1610.4%) |
| Date | Value |
|---|---|
| 2020 | -3.37(+32.7%) |
| 2019 | -2.54(+262.9%) |
| 2018 | -0.70(-73.9%) |
| 2017 | -2.68(-66.0%) |
| 2016 | -7.89 |
FAQ
- What is Cartesian Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cartesian Therapeutics?
- What is RNAC EV/EBITDA year-to-date change?
- What is Cartesian Therapeutics EV/EBITDA year-on-year change?
What is Cartesian Therapeutics EV/EBITDA?
The current EV/EBITDA of RNAC is -1.02
What is the all time high EV/EBITDA for Cartesian Therapeutics?
Cartesian Therapeutics all-time high EV/EBITDA is 5.66
What is RNAC EV/EBITDA year-to-date change?
Cartesian Therapeutics EV/EBITDA has changed by -0.05 (-5.15%) since the beginning of the year
What is Cartesian Therapeutics EV/EBITDA year-on-year change?
Over the past year, RNAC EV/EBITDA has changed by -0.86 (-537.50%)